Mixed Reactions to CMS Policy to Cut Back on Spending in 340B Program

A new Centers for Medicare & Medicaid Services (CMS) policy to redistribute savings under the 340B Drug Discount Program has been greeted by a mixture of praise and criticism from supporters and critics of the program.

Continue reading on Targeted Oncology.